Abstract
NCT01246206. The study was approved by Wayne State University Institutional Review Board.
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Adult
-
Aged
-
Allografts
-
Antilymphocyte Serum / therapeutic use*
-
Disease-Free Survival
-
Family
-
Female
-
Graft vs Host Disease / etiology
-
Graft vs Host Disease / prevention & control*
-
Hematologic Neoplasms / therapy
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Living Donors
-
Lymphocyte Transfusion
-
Male
-
Middle Aged
-
Tacrolimus / therapeutic use*
-
Treatment Failure
Substances
-
Antilymphocyte Serum
-
Immunosuppressive Agents
-
thymoglobulin
-
Tacrolimus